MODERNA INC reported first-quarter revenue of $389 million, exceeding analyst estimates of $228 million on strong international vaccine sales. International revenue reached $311 million, fueled by partnerships in the United Kingdom, Canada, and Australia. The shift toward global markets offsets declining demand in the United States following recent regulatory and policy changes.
Moderna Exceeds Revenue Estimates on International Sales
Moderna reported first-quarter revenue of $389 million, beating estimates behind strong international sales. The firm maintained its 2026 growth forecast.
Xurve View
Insights:
Xurve View







